Fukuda Denshi Valuation Multiples

Fukuda Denshi Overview

About Fukuda Denshi

Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm’s devices. Fukuda Denshi generates the vast majority of its sales in Japan.

Founded

1948

HQ

Employees

3.8K

Website

fukuda.co.jp

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $877M

EBITDA: $232M

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Fukuda Denshi Financials

Fukuda Denshi reported last 12-month revenue of $877M and EBITDA of $232M.

In the same LTM period, Fukuda Denshi generated $471M in gross profit, $232M in EBITDA, and $109M in net income.

Fukuda Denshi P&L

In the most recent fiscal year, Fukuda Denshi reported revenue of $952M and EBITDA of $250M.

Fukuda Denshi expects next 12-month revenue of XXX and NTM EBITDA of XXX

Fukuda Denshi Stock Performance

Fukuda Denshi has current market cap of $2B, and enterprise value of $1B.

Fukuda Denshi's stock price is $62.78.

Fukuda Denshi Valuation Multiples

Fukuda Denshi trades at 1.5x EV/Revenue multiple, and 5.6x EV/EBITDA.

Fukuda Denshi Financial Valuation Multiples

As of April 20, 2026, Fukuda Denshi has market cap of $2B and EV of $1B.

Equity research analysts estimate Fukuda Denshi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Fukuda Denshi has a P/E ratio of 15.5x.

Fukuda Denshi Margins & Growth Rates

Fukuda Denshi's revenue in the last 12 month grew by 3%.

Fukuda Denshi's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Fukuda Denshi's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Fukuda Denshi's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Fukuda Denshi Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Fukuda Denshi M&A Activity

Fukuda Denshi acquired XXX companies to date.

Last acquisition by Fukuda Denshi was on XXXXXXXX, XXXXX. Fukuda Denshi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Fukuda Denshi Investment Activity

Fukuda Denshi invested in XXX companies to date.

Fukuda Denshi made its latest investment on XXXXXXXX, XXXXX. Fukuda Denshi invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).